PALIVIZUMAB FOR PROPHYLAXIS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN CHILDREN WITH CYSTIC FIBROSIS: RESULTS OF A COCHRANE SYSTEMATIC REVIEW

被引:0
|
作者
Saldanha, I. [1 ]
Mckoy, N. A. [1 ]
Robinson, K. A. [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:331 / 331
页数:1
相关论文
共 50 条
  • [41] Respiratory syncytial virus bronchiolitis in congenital diaphragmatic hernia: A systematic review of prevalence rates and palivizumab prophylaxis
    Lewis, Leonie
    Sinha, Ian
    Losty, Paul D.
    PEDIATRIC PULMONOLOGY, 2022, 57 (01) : 239 - 244
  • [42] Palivizumab prophylaxis in patients admitted to the pediatric intensive care unit (PICU) with respiratory syncytial virus (RSV).
    Feller, AE
    Morrison, WE
    Straumanis, JP
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A92 - A92
  • [43] Use of palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis
    Speer, Michael E.
    Fernandes, Caraciolo J.
    Boron, Marnie
    Groothuis, Jessie R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (06) : 559 - 561
  • [44] Respiratory syncytial virus (RSV) infection in children with medical complexity
    A. Lim
    M. L. Butt
    J. Dix
    L. Elliott
    B. Paes
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 171 - 176
  • [45] Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review
    Wegzyn C.
    Toh L.K.
    Notario G.
    Biguenet S.
    Unnebrink K.
    Park C.
    Makari D.
    Norton M.
    Infectious Diseases and Therapy, 2014, 3 (2) : 133 - 158
  • [46] Clinical predictors of respiratory syncytial virus (RSV) infection in children
    Attia, MW
    Friedman, MJ
    PEDIATRIC RESEARCH, 2003, 53 (04) : 121A - 121A
  • [47] Respiratory syncytial virus (RSV) infection in children with medical complexity
    Lim, A.
    Butt, M. L.
    Dix, J.
    Elliott, L.
    Paes, B.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (01) : 171 - 176
  • [48] Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic Review
    Mac, Stephen
    Sumner, Amanda
    Duchesne-Belanger, Samuel
    Stirling, Robert
    Tunis, Matthew
    Sander, Beate
    PEDIATRICS, 2019, 143 (05)
  • [49] Prophylaxis with palivizumab against respiratory syncytial virus infection in infants with congenital heart disease -: who should receive it?
    Sunnegårdh, J
    ACTA PAEDIATRICA, 2006, 95 (04) : 388 - 390
  • [50] Respiratory Morbidity in Prematurely Born Children Receiving Palivizumab Prophylaxis of Respiratory Syncytial Virus Disease
    Bjelica, Milena
    Dautovic, Gordana Vilotijevic
    Spasojevic, Slobodan
    Dermanovic, Marija
    Plazacic, Milica
    IRANIAN JOURNAL OF NEONATOLOGY, 2024, 15 (02) : 3 - 12